Europese Unie - Nederlands - EMA (European Medicines Agency)

virbac s.a. - osateronacetaat - urologica - honden - behandeling van goedaardige prostaathypertrofie (bph) bij reuen.

Europese Unie - Nederlands - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

medcor pharmaceuticals b.v. artemisweg 232 8239 de lelystad - testosteronundecanoaat - capsule, zacht - castorolie ; gelatine (e 441) ; glycerol (e 422) ; propyleenglycolmonolauraat, type i (e 477) ; zonnegeel fcf (e 110) - testosterone

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

testosteronundecanoaat 250 mg/ml samenstelling overeenkomend met ; testosteron 157,9 µg/ml - oplossing voor injectie - benzylbenzoaat ; castorolie, gezuiverd

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

testosteronundecanoaat 250 mg/ml samenstelling overeenkomend met ; testosteron 157,9 mg/ml - oplossing voor injectie - benzylbenzoaat ; castorolie, gezuiverd

Europese Unie - Nederlands - EMA (European Medicines Agency)

mylan ireland limited - abirateronacetaat - prostaatnoplasma - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Europese Unie - Nederlands - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

besins healthcare sa-nv - testosteronundecylaat 1000 mg/4 ml - eq. testosteron 631,5 mg/4 ml - oplossing voor injectie - testosterone

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

besins healthcare sa-nv - testosteron 0,041 g - gel voor transdermaal gebruik in zakje - 40,5 mg - testosteron 16.4 mg/g - testosterone

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

besins healthcare sa-nv - testosteron 0,025 g - gel voor transdermaal gebruik - 25 mg - testosteron 25 mg - testosterone